| Phase 3 |
| NCT06498479 |
ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung… |
Small Cell Lung Cancer |
Recruiting |
| NCT06855069 |
HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian… |
Ovarian Cancer |
Recruiting |
| NCT06526624 |
A Study of HS-20093 vs Active Surveillance in Limited-Stage Small Cell Lung Cancer |
Limited-stage Small-cell Lung Cancer |
Not Yet Recruiting |
| NCT06672393 |
A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis |
Psoriasis |
Not Yet Recruiting |
| NCT06844799 |
A Study of HS-20137 in Participants with Moderate-to-severe Plaque Psoriasis |
Moderate-to-severe Plaque Psoriasis |
Not Yet Recruiting |
| NCT07464327 |
A Phase III Study of HS-20093 Injection Combined With Adebrelimab Versus Docetaxel in… |
Non-Small Cell Lung Cancer |
Not Yet Recruiting |
| NCT06935409 |
Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of… |
Osteosarcoma |
Active, Not Recruiting |
| NCT07621601 |
A Study of HS-20093 in Patients With Pretreated Advanced or Metastatic Esophageal… |
Esophageal Squamous Cell Carcinoma (ESCC) |
Not Yet Recruiting |
| Phase 2/3 |
| NCT06417008 |
A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous… |
Non-Squamous Non-Small Cell Lung Cancer |
Recruiting |
| Phase 2 |
| NCT06176508 |
Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic… |
Psoriatic Arthritis |
Recruiting |
| NCT06007729 |
ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other… |
Head and Neck Squamous Cell Carcinoma |
Recruiting |
| NCT05830123 |
ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other… |
Osteosarcoma |
Recruiting |
| NCT06014190 |
HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer |
Ovarian Cancer |
Recruiting |
| NCT06112704 |
HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid Tumors |
Advanced Solid Tumor |
Recruiting |
| NCT06594965 |
A Study of HS-20106 to Treat Anemia Due to Very Low, Low, or Intermediate Risk… |
Myelodysplastic Syndromes |
Not Yet Recruiting |
| NCT06635772 |
A Study of the Effect and Safety of HS-10390 in the Treatment of Patients with Primary… |
Immunoglobulin a Nephropathy |
Not Yet Recruiting |
| NCT06926582 |
A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis |
Psoriasis |
Not Yet Recruiting |
| Phase 1/2 |
| NCT07283367 |
A Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer… |
CRC |
Recruiting |
| NCT06144723 |
Study of HS-20105 for Injection in Patients With Advanced Solid Tumors. |
Advanced Solid Tumor |
Not Yet Recruiting |
| Phase 1 |
| NCT06332170 |
ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors |
Advanced Solid Tumor |
Recruiting |
| NCT06336707 |
HS-20089 Combination Treatment in Subjects With Advanced Solid Tumors |
Advanced Solid Tumors |
Recruiting |
| NCT05942625 |
A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in… |
IgA Nephropathy |
Recruiting |
| NCT06763159 |
A Study of HS-20124 in Patients with Advanced Solid Tumors |
Solid Cancer |
Recruiting |
| NCT06825624 |
ARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal Cancer |
Metastatic Colorectal Cancer (CRC) |
Recruiting |
| NCT06621563 |
Phase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid Tumors |
Solid Tumors |
Recruiting |